RBSΒ Research

Collaborations Driving Longevity Research

We work alongside top scientists to:

Expand the collective knowledge of aging and longevity.

Investigate molecular pathways through cell and animal studies.

Assess the real-world clinical effectiveness of our products.

Ongoing Collaborations and Research Projects

NAD+ Complete Clinical Trial

In collaboration with Citruslabs - Recipient of the 2025 Citruslabs Research Grant

Objective: To conduct a randomized, triple-blind, placebo-controlled clinical trial evaluating NAD+ Complete for its effects on blood NAD+ levels and key wellness outcomes, including energy, mood, sleep quality, mental clarity, and fatigue.

Status: Trial initiation planned for November 2025.

My NAD+ Test

In collaboration with Dr. Qiuliyang Yu, Shenzhen Institute of Advanced Technology

Objective: To develop an at-home dried blood spot NAD+ testing kit that enables convenient and accessible measurement of NAD+ levels for research and consumer use.

Status: Currently in development.

Renue Blue: Mechanisms & Clinical Efficacy

In collaboration with Dr. Jiankang Liu, Xi'an Jiaotong University, China

Objective: To evaluate Renue Blue skincare formulationsβ€”individually and in combinationβ€”for their effects on mitochondrial function, antioxidant defense systems, and other cellular mechanisms involved in skin aging. The research spans in-vitro (cell-based) and in-vivo (animal) models, with a follow-up clinical trial assessing visible and molecular markers of skin aging.

Status: Cell culture studies are currently underway. Animal and clinical testing are scheduled for 2026.

NAD+ Complete Nasal Spray & Glaucoma

In collaboration with Dr. Kenneth Shindler and Dr. Ahmara Ross, Perelman School of Medicine at the University of Pennsylvania

Objective: To evaluate intranasal NAD+ Complete for its potential to protect retinal ganglion cells in a high intraocular pressure (IOP) glaucoma model.

Status: Pilot study completed; progression to a larger-scale animal study is underway.